Nanaimo Regional Conference: Parkinson's Overview (2016)

Dr. Martin McKeown, Director of the Movement Disorder Clinic at the University of British Columbia, delivered a comprehensive talk on Parkinson's disease. He covered symptoms, diagnosis challenges, and the role of dopamine in the brain. The talk highlighted early warning signs including loss of smell, anxiety, and stiffness, while exploring biomarkers for diagnosis such as dopamine levels and brain wave patterns. Treatment options like levodopa and deep brain stimulation were discussed, along with cautionary notes on therapies relying on the placebo effect.

Advancements in monitoring methods, brain stimulation, and gut microbiome studies were mentioned as promising research avenues. The connection between Lewy body disease and Parkinson's with dementia remains an open question, prompting interest in further clinical studies. Dr. McKeown outlined differences in cognitive impairment between Parkinson's and Alzheimer's. He also touched upon topics such as medication timing and meal intake, suggesting adjustments for optimal levodopa absorption. Sleep issues were addressed, considering factors like medication wearing off and bladder instability, with varied treatment approaches recommended.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**